Cargando…

577. COVI-VAC™, a Live Attenuated COVID-19 Vaccine, Provides Single Dose Protection Against Heterologous Challenge with SARS-CoV-2 Beta (B.1.351) in the Syrian Golden Hamster Model

BACKGROUND: Although multiple COVID-19 vaccines are currently in use, emergence of novel SARS-CoV-2 variants with reduced neutralization raises concern of future vaccine escape. COVI-VAC™ is a live attenuated SARS-CoV-2 strain based on WA/1 being developed as an intranasal COVID-19 vaccine. COVI-VAC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kushnir, Anna, Mueller, Steffen, Tasker, Sybil, Robert Coleman, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644885/ http://dx.doi.org/10.1093/ofid/ofab466.775

Ejemplares similares

584. Phase 1 Placebo-Controlled Trial of COVI-VAC™, an Intranasal, Live Attenuated COVID-19 Vaccine
por: Tasker, Sybil, et al.
Publicado: (2021)

A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters
por: Wuertz, Kathryn McGuckin, et al.
Publicado: (2021)

Generation of transgenic golden Syrian hamsters
por: Gao, Mingming, et al.
Publicado: (2014)

Golden Syrian Hamster Models for Cancer Research
por: Wang, Zhongde, et al.
Publicado: (2022)

The production of skin lesions and lymphocytic leukemia in the Syrian (golden) hamster.
por: Fortner, J. G.
Publicado: (1965)

Rift Valley Fever Virus Infection in Golden Syrian Hamsters
por: Scharton, Dionna, et al.
Publicado: (2015)

ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
por: Fischer, Robert J., et al.
Publicado: (2021)

ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
por: Fischer, Robert J., et al.
Publicado: (2021)

An immunosuppressed Syrian golden hamster model for SARS-CoV infection
por: Schaecher, Scott R., et al.
Publicado: (2008)

Phytosterols protect against diet-induced hypertriglyceridemia in Syrian golden hamsters
por: Rideout, Todd C, et al.
Publicado: (2014)

Experimental Models in Syrian Golden Hamster Replicate Human Acute Pancreatitis
por: Wang, Yunan, et al.
Publicado: (2016)

Pathogenesis and transmission of SARS-CoV-2 in golden Syrian hamsters
por: Sia, Sin Fun, et al.
Publicado: (2020)

RELATION OF CERTAIN ENDOCRINE DISTURBANCES TO SUSCEPTIBILITY OF GOLDEN SYRIAN HAMSTER TO EXPERIMENTAL POLIOMYELITIS
por: Teodoru, Constantin V., et al.
Publicado: (1954)

Chronic effects of dietary exposure to amosite and chrysotile asbestos in Syrian golden hamsters.
por: McConnell, E E, et al.
Publicado: (1983)

Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus)
por: Zivcec, Marko, et al.
Publicado: (2011)

Efficient Gene Targeting in Golden Syrian Hamsters by the CRISPR/Cas9 System
por: Fan, Zhiqiang, et al.
Publicado: (2014)

Corrigendum: Experimental Models in Syrian Golden Hamster Replicate Human Acute Pancreatitis
por: Wang, Yunan, et al.
Publicado: (2016)

COVID-19 rise in Bangladesh correlates with increasing detection of B.1.351 variant
por: Saha, Senjuti, et al.
Publicado: (2021)

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021)

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021)

Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters
por: Hammerbeck, Christopher D., et al.
Publicado: (2016)

Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters
por: Westover, Jonna B., et al.
Publicado: (2018)

The golden (Syrian) hamster as a model for the study of reproductive biology: Past, present, and future
por: Hirose, Michiko, et al.
Publicado: (2018)

A novel cancer syndrome caused by KCNQ1-deficiency in the golden Syrian hamster
por: Li, Rong, et al.
Publicado: (2018)

Using a Syrian (Golden) Hamster Biological Model for the Evaluation of Recombinant Anthrax Vaccines
por: Kravchenko, Tatiana, et al.
Publicado: (2021)

1938. CoviLiv™, a Novel Intranasal Live-Attenuated COVID-19 Vaccine Candidate, Induces Robust Humoral and Cellular Immunity in First-In-Human Clinical Trial CDX-CoV-001
por: Kaufmann, Johanna K, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
por: Shen, Xiaoying, et al.
Publicado: (2021)

The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice
por: Zhang, Cheng, et al.
Publicado: (2022)

Distribution and photodynamic effect of disulphonated aluminium phthalocyanine in the pancreas and adjacent tissues in the Syrian golden hamster.
por: Nuutinen, P. J., et al.
Publicado: (1991)

The Effect of Concomitant Ethanol and Opium Consumption on Lipid Profiles and Atherosclerosis in Golden Syrian Hamster’s Aorta
por: Shahryari, Jahanbanoo, et al.
Publicado: (2013)

Antihyperlipidemic and Antioxidant Effects of C-phycocyanin in Golden Syrian Hamsters Fed with a Hypercholesterolemic Diet
por: Sheu, Ming-Jyh, et al.
Publicado: (2013)

Viral MicroRNA Effects on Pathogenesis of Polyomavirus SV40 Infections in Syrian Golden Hamsters
por: Zhang, Shaojie, et al.
Publicado: (2014)

The Metabolic Changes of Artesunate and Ursolic Acid on Syrian Golden Hamsters Fed with the High-Fat Diet
por: Pu, Shichen, et al.
Publicado: (2020)

SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters
por: Qiao, Wei, et al.
Publicado: (2022)

Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2
por: Becker, Kathrin, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Vasculopathy in a Syrian Golden Hamster Model
por: Ball, Erin E., et al.
Publicado: (2023)

The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
por: Kim, Yeong Jun, et al.
Publicado: (2021)

Detection of B.1.351 SARS-CoV-2 Variant Strain — Zambia, December 2020
por: Mwenda, Mulenga, et al.
Publicado: (2021)

Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant
por: Shinde, Vivek, et al.
Publicado: (2021)

The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
por: Ruscheweyh, Ruth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_avess6g0etoj8kutqdj8aenc9k